Hypertension, Systolic
9
3
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
11%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)
Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction
Sympathetic Regulation of Large Artery Stiffness in Humans With ISH
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Treatment of Hypertension During Sleep
Olive Polyphenols in Cardiovascular Prevention
A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People